Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...

Medications known as GLP-1 receptor agonists have become some of the most popular treatments for weight loss in recent years. These drugs, originally developed to help people with diabetes control ...

For many people, recovery from a heart attack is a journey that requires careful lifestyle tweaks and long-term medication ...

As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings.

Consumers filed over 200 complaints with some telemedicine companies for misleading customers about costs of weight loss using GLP-1 drugs.

A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial ...

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

Tirzepatide, which is marketed as Zepbound for chronic weight management, is a dual GIP and GLP-1 receptor agonist that has ...

By Dennis Thompson HealthDay ReporterTHURSDAY, March 12, 2026 (HealthDay News) — People frequently switch between different weight-loss drugs, swapping Ozempic for Zepbound and vice versa within the ...

A diabetologist attributes his 37 kg weight loss to structured exercise and metabolic correction, emphasising insulin control and sustainable habits. | Health ...

A real-world study finds that adults with obesity or overweight and related comorbidities who receive antiobesity medications through a telehealth clinic achieve substantial long-term weight loss.

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) ...